Civic Intelligence

Eicosanoid Research Foundation

990EZ • Fiscal year 2014 • EIN 27-0097769

Jan 01, 2014 to Dec 31, 2014 • Filed on Jul 30, 2015

Organization ProfileWWW.EICOSANOIDRESEARCHFOUNDATION.ORG
5101 Cass Ave 431 Chemistry BldgDetroit, MI 48202

(313) 577-1018

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on this filing.

Source year 2014

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on this filing.

Source year 2014

Net Margin

88th percentile

38%

Higher net margin than 88% of similar nonprofits.

2014 filings • 501(c)3 • <$500k nonprofits • Source year 2014

Top Officer Pay

74th percentile

$0

Higher top officer pay than 74% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2014 filings • 501(c)3 • <$500k nonprofits • Source year 2014

Asset Growth

99th percentile

1661%

Faster asset growth than 99% of similar nonprofits.

2014 filings • 501(c)3 • <$500k nonprofits • Annualized from 2013 to 2014

Revenue Growth

4th percentile

-79%

Faster revenue growth than 4% of similar nonprofits.

2014 filings • 501(c)3 • <$500k nonprofits • Annualized from 2013 to 2014

Balance Sheet
Liabilities / AssetsScore unavailable

Assets

Up

$14,630

Up $13,799 (+1661%) from 2013

Net Assets

Up

$14,630

Up $13,799 (+1661%) from 2013

Liabilities

-

No earlier filing loaded for comparison.

Revenue And Expenses
Liabilities / RevenueScore unavailableNet Margin88th percentile

Revenue

Down

$36,573

Down $139,489 (-79%) from 2013

Expenses

Down

$22,774

Down $197,211 (-90%) from 2013

Net Income

Up

$13,799

Up $57,722 (+131%) from 2013

Historical Trend

Balance Sheet Trend

Asset Growth99th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100K$50K$0-$50KAssets 2011: $65,562Liabilities 2011: $0Net Assets 2011: $65,5622011Assets 2012: $44,754Net Assets 2012: $44,7542012Assets 2013: $831Net Assets 2013: $8312013Assets 2014: $14,630Net Assets 2014: $14,6302014Assets 2015: $12,688Net Assets 2015: $12,6882015Assets 2016: $39,489Net Assets 2016: $39,4892016Assets 2017: $71,362Liabilities 2017: $0Net Assets 2017: $71,3622017Assets 2018: $45,889Liabilities 2018: $3,020Net Assets 2018: $42,8692018Assets 2019: $77,621Liabilities 2019: $0Net Assets 2019: $77,6212019Assets 2020: $27,594Liabilities 2020: $1,699Net Assets 2020: $25,8952020Assets 2021: $88,983Liabilities 2021: $4,745Net Assets 2021: $84,2382021Assets 2022: $17,889Liabilities 2022: $0Net Assets 2022: $17,8892022Assets 2023: $10,801Liabilities 2023: -$742Net Assets 2023: $11,5432023

Highlighted filing

2014

Assets$14,630
Liabilities-
Net Assets$14,630
Open 2014 Filing

Operations Trend

Revenue Growth4th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$400K$300K$200K$100K$0-$100KExpenses 2011: $303,4022011Revenue 2012: $445Expenses 2012: $21,253Net Income 2012: -$20,8082012Revenue 2013: $176,062Expenses 2013: $219,985Net Income 2013: -$43,9232013Revenue 2014: $36,573Expenses 2014: $22,774Net Income 2014: $13,7992014Revenue 2015: $165,204Expenses 2015: $167,146Net Income 2015: -$1,9422015Revenue 2016: $46,961Expenses 2016: $14,415Net Income 2016: $32,5462016Revenue 2017: $255,293Expenses 2017: $227,286Net Income 2017: $28,0072017Revenue 2018: $28,463Expenses 2018: $56,956Net Income 2018: -$28,4932018Revenue 2019: $261,031Expenses 2019: $226,279Net Income 2019: $34,7522019Revenue 2020: $5,003Expenses 2020: $56,729Net Income 2020: -$51,7262020Revenue 2021: $78,803Expenses 2021: $20,460Net Income 2021: $58,3432021Revenue 2022: $265,748Expenses 2022: $332,097Net Income 2022: -$66,3492022Revenue 2023: $20,080Expenses 2023: $26,426Net Income 2023: -$6,3462023

Highlighted filing

2014

Revenue$36,573
Expenses$22,774
Net Income$13,799
Open 2014 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2014 to Dec 31, 2014
Signed
Jul 30, 2015
Return Version
2014v5.0
Gross Receipts
$36,573
Mission and Program Overview

Mission

The primary exempt purpose of the eicosanoid research foundation is to provide a forum for the dissemination of the latest scientific information on bioactive lipids in health and disease as it relates to cancer, inflamation and inflamation induced diseases such as cardiovascular, diabetes, psoriasis and alzheimer's. This purpose is accomplished through the organization's bi-annual conference. The eicosanoid research foundation sponsors bi-annual conferences highlighting data at the cutting edge of medical science. During these conferences new drugs and medications are discussed, data on clinical trials is examined and scientists from all over the world interact to enhance their collaborative research efforts. The goal of this meeting series is to promote the exchange of information and ideas among international scientists of diverse backgrounds.the main purpose of the eicosanoid research foundation is to raise funds to sponsor the international conference on bioactive lipids in cancer

The purpose of the eicosanoid research foundation (erf) is to provide a forum for the dissemination of the latest scientific information on bioactive lipids in health and disease as it relates to cancer, inflamation and inflamation induced diseases such as cardiovascular, diabetes, psoriasis and alzheimer's. The eicosanoid research foundation sponsors bi-annual conferences highlighting data at the cutting edge of medical science. During these conferences new drugs and medications are discussed, data on clinical trials is examined and scientists interact to enhance their collaborative research efforts. The goal of this meeting series is to promote the exchange of information and ideas amoung scientists of diverse backgrounds from around the world. The sole purpose of the eicosanoid research foundation is to raise funds to sponsor the international conference on bioactive lipids in cancer, inflammation and related diseases thereby promoting advances in this area of science and medical re

Program Services

DescriptionGrantsExpenses
THE ORGANIZATION HELD AN INFORMATIVE AND SUCCESSFUL CONFERENCE IN THE FALL OF 2013 RELATING TO THE DISSEMINATION OF THE LATEST SCIENTIFIC AND MEDICAL INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE, AS THEY RELATE TO CANCER. THE CONFERENCE SUCCESSFULLY PROMOTED THE EXCHANGE OF IDEAS AND THEORIES IN THIS AREA AMOUNG SCIENTISTS AND MEDICAL PROFESSIONALS AROUND THE WORLD, IN AN EFFORT TO FIND A CURE FOR CANCER. THE ORGANIZATION IS CURRENTLY PLANNING ITS 2015 BI-ANNUAL CONFERENCE TO BE HELD IN BUDAPEST, HUNGARY.-$17,595
Compensation and Service Providers
Top Officer Pay74th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
DR KENNETH V HONNDirector-$0--
DR EDWARD DENNISDirector-$0--
DR LARRY MARNETTDirector-$0--
DR CHARLES SERHANDirector-$0--
DR GABOR J TIGYIDirector-$0--
Filing and Contact Details

Filer

Filer Name
Eicosanoid Research Foundation
EIN
27-0097769
Phone
3135771018
Address
5101 CASS AVE 431 CHEMISTRY BLDG, DETROIT, MI 48202

Signing Officer

Name
Dr Kenneth V Honn
Title
Director
Phone
3135771018
Signed
2015-07-30
Discuss with paid preparer
Yes

Preparer

Firm
Graves & Company Pc
Address
20550 VERNIER RD, HARPER WOODS, MI 48225-1413
Preparer
Lawrence B Graves Jr CPA
Phone
3138868892
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16

“Expenses conference travel expenses 6,982 annual report fees 20 bank charges/ fees 401 website/computer expenses 722 michigan registration fee 25 total 8,150”

Form 990-ez, Part III

“The purpose of the eicosanoid research foundation (erf) is to provide a forum for the dissemination of the latest scientific information on bioactive lipids in health and disease as it relates to cancer, inflamation and inflamation induced diseases such as cardiovascular, diabetes, psoriasis and alzheimer's. The eicosanoid research foundation sponsors bi-annual conferences highlighting data at the cutting edge of medical science. During these conferences new drugs and medications are discussed, data on clinical trials is examined and scientists interact to enhance their collaborative research efforts. The goal of this meeting series is to promote the exchange of information and ideas amoung scientists of diverse backgrounds from around the world. The sole purpose of the eicosanoid research foundation is to raise funds to sponsor the international conference on bioactive lipids in cancer, inflammation and related diseases thereby promoting advances in this area of science and medical research.”

Form 990-ez, Part III, Line 28

“The organization held an informative and successful conference in the fall of 2013 relating to the dissemination of the latest scientific and medical information on bioactive lipids in health and disease, as they relate to cancer. The conference successfully promoted the exchange of ideas and theories in this area amoung scientists and medical professionals around the world, in an effort to find a cure for cancer. The organization is currently planning its 2015 bi-annual conference to be held in budapest, hungary.”

Raw XML Appendix172 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0CHRISTOPHER HARRIS
IRS990EZ/BooksInCareOfDetail/PhoneNum03135771018
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt05101 CASS AVE 431 CHEMISTRY BLDG
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0DETROIT
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MI
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd048202
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0831
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt014630
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt032462
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt013799
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt010695
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0831
IRS990EZ/Form990TotalAssetsGrp/EOYAmt014630
IRS990EZ/GrossReceiptsAmt036573
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt01
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0831
IRS990EZ/NetAssetsOrFundBalancesEOYAmt014630
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0831
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt014630
IRS990EZ/OccupancyRentUtltsAndMaintAmt03113
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt03.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt12.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt22.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt32.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt42.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0DR KENNETH V HONN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1DR EDWARD DENNIS
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2DR LARRY MARNETT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3DR CHARLES SERHAN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4DR GABOR J TIGYI
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4DIRECTOR
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt08150
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0THE PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION (ERF) IS TO PROVIDE A FORUM FOR THE DISSEMINATION OF THE LATEST SCIENTIFIC INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE AS IT RELATES TO CANCER, INFLAMATION AND INFLAMATION INDUCED DISEASES SUCH AS CARDIOVASCULAR, DIABETES, PSORIASIS AND ALZHEIMER'S. THE EICOSANOID RESEARCH FOUNDATION SPONSORS BI-ANNUAL CONFERENCES HIGHLIGHTING DATA AT THE CUTTING EDGE OF MEDICAL SCIENCE. DURING THESE CONFERENCES NEW DRUGS AND MEDICATIONS ARE DISCUSSED, DATA ON CLINICAL TRIALS IS EXAMINED AND SCIENTISTS INTERACT TO ENHANCE THEIR COLLABORATIVE RESEARCH EFFORTS. THE GOAL OF THIS MEETING SERIES IS TO PROMOTE THE EXCHANGE OF INFORMATION AND IDEAS AMOUNG SCIENTISTS OF DIVERSE BACKGROUNDS FROM AROUND THE WORLD. THE SOLE PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO RAISE FUNDS TO SPONSOR THE INTERNATIONAL CONFERENCE ON BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RELATED DISEASES THEREBY PROMOTING ADVANCES IN THIS AREA OF SCIENCE AND MEDICAL RE
IRS990EZ/PrintingPublicationsPostageAmt0816
IRS990EZ/ProgramServiceRevenueAmt04110
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0THE ORGANIZATION HELD AN INFORMATIVE AND SUCCESSFUL CONFERENCE IN THE FALL OF 2013 RELATING TO THE DISSEMINATION OF THE LATEST SCIENTIFIC AND MEDICAL INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE, AS THEY RELATE TO CANCER. THE CONFERENCE SUCCESSFULLY PROMOTED THE EXCHANGE OF IDEAS AND THEORIES IN THIS AREA AMOUNG SCIENTISTS AND MEDICAL PROFESSIONALS AROUND THE WORLD, IN AN EFFORT TO FIND A CURE FOR CANCER. THE ORGANIZATION IS CURRENTLY PLANNING ITS 2015 BI-ANNUAL CONFERENCE TO BE HELD IN BUDAPEST, HUNGARY.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt017595
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0MI
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt022774
IRS990EZ/TotalProgramServiceExpensesAmt017595
IRS990EZ/TotalRevenueAmt036573
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.EICOSANOIDRESEARCHFOUNDATION.ORG
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt032462
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt062150
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt0350
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt0197850
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt0156500
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0449312
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt01
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt010
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt06
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt010
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt01
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt028
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt04111
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt0113912
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt095
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt0103667
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0221785
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt01
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt010
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt06
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt010
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt01
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt028
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/InvestmentIncomePYPct00.00000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.64360
IRS990ScheduleA/PublicSupportPY509Pct00.64120
IRS990ScheduleA/PublicSupportTotal509Amt0431945
IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/CurrentTaxYearAmt031573
IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/CurrentTaxYearMinus1YearAmt0108912
IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/CurrentTaxYearMinus3YearsAmt098667
IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/TotalAmt0239152
IRS990ScheduleA/SubstantialContributorsAmtGrp/CurrentTaxYearAmt031573
IRS990ScheduleA/SubstantialContributorsAmtGrp/CurrentTaxYearMinus1YearAmt0108912
IRS990ScheduleA/SubstantialContributorsAmtGrp/CurrentTaxYearMinus3YearsAmt098667
IRS990ScheduleA/SubstantialContributorsAmtGrp/TotalAmt0239152
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt036573
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0176062
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0445
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0301517
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0156500
IRS990ScheduleA/Total509Grp/TotalAmt0671097
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt036574
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0176072
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0451
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0301527
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0156501
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0671125
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0EXPENSES CONFERENCE TRAVEL EXPENSES 6,982 ANNUAL REPORT FEES 20 BANK CHARGES/ FEES 401 WEBSITE/COMPUTER EXPENSES 722 MICHIGAN REGISTRATION FEE 25 TOTAL 8,150
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1THE PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION (ERF) IS TO PROVIDE A FORUM FOR THE DISSEMINATION OF THE LATEST SCIENTIFIC INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE AS IT RELATES TO CANCER, INFLAMATION AND INFLAMATION INDUCED DISEASES SUCH AS CARDIOVASCULAR, DIABETES, PSORIASIS AND ALZHEIMER'S. THE EICOSANOID RESEARCH FOUNDATION SPONSORS BI-ANNUAL CONFERENCES HIGHLIGHTING DATA AT THE CUTTING EDGE OF MEDICAL SCIENCE. DURING THESE CONFERENCES NEW DRUGS AND MEDICATIONS ARE DISCUSSED, DATA ON CLINICAL TRIALS IS EXAMINED AND SCIENTISTS INTERACT TO ENHANCE THEIR COLLABORATIVE RESEARCH EFFORTS. THE GOAL OF THIS MEETING SERIES IS TO PROMOTE THE EXCHANGE OF INFORMATION AND IDEAS AMOUNG SCIENTISTS OF DIVERSE BACKGROUNDS FROM AROUND THE WORLD. THE SOLE PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO RAISE FUNDS TO SPONSOR THE INTERNATIONAL CONFERENCE ON BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RELATED DISEASES THEREBY PROMOTING ADVANCES IN THIS AREA OF SCIENCE AND MEDICAL RESEARCH.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2THE ORGANIZATION HELD AN INFORMATIVE AND SUCCESSFUL CONFERENCE IN THE FALL OF 2013 RELATING TO THE DISSEMINATION OF THE LATEST SCIENTIFIC AND MEDICAL INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE, AS THEY RELATE TO CANCER. THE CONFERENCE SUCCESSFULLY PROMOTED THE EXCHANGE OF IDEAS AND THEORIES IN THIS AREA AMOUNG SCIENTISTS AND MEDICAL PROFESSIONALS AROUND THE WORLD, IN AN EFFORT TO FIND A CURE FOR CANCER. THE ORGANIZATION IS CURRENTLY PLANNING ITS 2015 BI-ANNUAL CONFERENCE TO BE HELD IN BUDAPEST, HUNGARY.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART III
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART III, LINE 28
ReturnHeader/BuildTS02016-02-25 16:41:14Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0DR KENNETH V HONN
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum03135771018
ReturnHeader/BusinessOfficerGrp/SignatureDt02015-07-30
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0EICOSANOID RESEARCH FOUNDATION
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0C/O DR KENNETH V HONN
ReturnHeader/Filer/BusinessNameControlTxt0EICO
ReturnHeader/Filer/EIN0270097769
ReturnHeader/Filer/PhoneNum03135771018
ReturnHeader/Filer/USAddress/AddressLine1Txt05101 CASS AVE 431 CHEMISTRY BLDG
ReturnHeader/Filer/USAddress/CityNm0DETROIT
ReturnHeader/Filer/USAddress/StateAbbreviationCd0MI
ReturnHeader/Filer/USAddress/ZIPCd048202
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0382886069
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0GRAVES & COMPANY PC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt020550 VERNIER RD
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0HARPER WOODS
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0MI
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0482251413
ReturnHeader/PreparerPersonGrp/PhoneNum03138868892
ReturnHeader/PreparerPersonGrp/PreparationDt02015-08-11
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0LAWRENCE B GRAVES JR CPA
ReturnHeader/ReturnTs02015-08-11T09:32:17-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02014-01-01
ReturnHeader/TaxPeriodEndDt02014-12-31
ReturnHeader/TaxYr02014

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2014 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$14,630
Liabilities
-
Net assets
$14,630
Revenue
$36,573
Expenses
$22,774
Net income
$13,799
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2023Detailed filing. Detailed filing data is available for this year.$0.11$0.01$0.12$0.20$0.26$0.06
2022Detailed filing. Detailed filing data is available for this year.$0.18$0.00$0.18$2.66$3.32$0.66
2021Detailed filing. Detailed filing data is available for this year.$0.89$0.05$0.84$0.79$0.20$0.58
2020Detailed filing. Detailed filing data is available for this year.$0.28$0.02$0.26$0.05$0.57$0.52
2019Detailed filing. Detailed filing data is available for this year.$0.78$0.00$0.78$2.61$2.26$0.35
2018Detailed filing. Detailed filing data is available for this year.$0.46$0.03$0.43$0.28$0.57$0.28
2017Detailed filing. Detailed filing data is available for this year.$0.71$0.00$0.71$2.55$2.27$0.28
2016Detailed filing. Detailed filing data is available for this year.$0.39$0.39$0.47$0.14$0.33
2015Detailed filing. Detailed filing data is available for this year.$0.13$0.13$1.65$1.67$0.02
2014Detailed filing. Detailed filing data is available for this year.$0.15$0.15$0.37$0.23$0.14
2013Detailed filing. Detailed filing data is available for this year.$0.01$0.01$1.76$2.20$0.44
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.45$0.45$0.00$0.21$0.21
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.66$0.00$0.66$3.03